Mass spectrometry analysis confirms molecular structure and active ingredients meet specification
GLP-1 medications work by enhancing insulin secretion, suppressing glucagon, delaying gastric emptying, and regulating appetite through glucose-dependent mechanisms
The most plausible confounding factor is malaise, which is a common side effect of the GLP-1R agonists used (Kanoski et al., 2012)
Sources: Drug Shortages | FDA FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA Facts About the Current Good Manufacturing Practice (CGMP) | FDA FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products | FDA FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown
Plus, when you stop taking it, the feelings of suppressed appetite will start to go away and people will start to feel hungry at their old levels